Fig. 7

Positron emission tomography/Computed tomography (PET/CT) of representative NSCLC patients with metastasis before and after P-A combination therapy. A Patient No.1 harboring EGFR del19 mutant, TP53 mutation and EGFR amplification with pleural metastases. B Patient No.2 harboring EGFR del19 mutant and TP53 mutation with multiple pleural metastases. Arrows represent where the primary tumor and metastasis were performed